Condition: Parkinson Disease · Nervous System Disorder · Neurodegenerative Diseases · Sponsor: University of Exeter
In this study, the investigators aim to find a biomarker of Parkinson's disease. This is done using imaging scans called Positron Emission tomography (PET), Single Photon Emission Computed Tomography (SPECT), and Magnetic Resonance Imaging (MRI). The findings will provide a deeper understanding of the brain changes in Parkinson's disease. More importantly, this study will help with the discovery and development of new medications aiming to delay progression of PD symptoms.
This description comes directly from the study's public registry record.
Marios Politis, Professor · 07503 741242 · m.politis@exeter.ac.uk
Edoardo de Natale, Dr · 07503 741242 · e.de-natale@exeter.ac.uk
Always discuss trial participation with your own doctor first.
| University Of Exeter | Exeter, Devon, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05518617